azomycin has been researched along with Biliary Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corpechot, C; Galy, B; Housset, C; Poupon, R; Raleigh, J; Rosmorduc, O; Sebbagh, N; Wendum, D | 1 |
1 other study(ies) available for azomycin and Biliary Cirrhosis
| Article | Year |
|---|---|
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.
Topics: Animals; Blotting, Western; Cell Hypoxia; Endothelial Growth Factors; Fibroblast Growth Factor 2; Immunohistochemistry; Ki-67 Antigen; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Lymphokines; Male; Neovascularization, Pathologic; Nitroimidazoles; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |